🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

132+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 132 recruiting trials for “precursor-t-cell-acute-lymphoblastic-leukemia”

RecruitingNCT03568266 ↗

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

👨‍⚕️ Houda Alachkar, Ph.D., University of Southern California📍 1 site📅 Started May 2018View details ↗
Phase 1, PHASE2RecruitingNCT03128034 ↗

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

👨‍⚕️ Brenda M. Sandmaier, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Oct 2017View details ↗
Phase 2RecruitingNCT03136146 ↗

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

👨‍⚕️ Maro Ohanian, M.D. Anderson Cancer Center📍 1 site📅 Started Aug 2017View details ↗
Phase 1, PHASE2RecruitingNCT03104491 ↗

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

👨‍⚕️ Leland Metheny, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 7 sites📅 Started Jul 2017View details ↗
Phase 1, PHASE2RecruitingNCT03984968 ↗

CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia

🏥 The First Affiliated Hospital of Soochow University📍 1 site📅 Started Jul 2017View details ↗
Phase 2RecruitingNCT02997761 ↗

Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia

👨‍⚕️ Brian Jonas, University of California, Davis📍 1 site📅 Started Jun 2017View details ↗
NARecruitingNCT01962636 ↗

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

👨‍⚕️ Claudio Brunstein, MD, University of Minnesota📍 1 site📅 Started Dec 2016View details ↗
Phase 1RecruitingNCT02443831 ↗

CARPALL: Immunotherapy with CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia

👨‍⚕️ Persis Amrolia, UCL Institute of Child Health📍 3 sites📅 Started Apr 2016View details ↗
Phase 2Enrolling by InvitationNCT02646839 ↗

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

👨‍⚕️ Michael Pulsipher, MD, Children's Hospital Los Angeles📍 11 sites📅 Started Oct 2015View details ↗
Phase 4RecruitingNCT02670564 ↗

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

👨‍⚕️ Christina Peters, Prof. MD PhD, St. Anna Kinderspital, Vienna, Austria📍 4 sites📅 Started Apr 2013View details ↗
Phase 1, PHASE2RecruitingNCT01371630 ↗

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

👨‍⚕️ Elias Jabbour, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Aug 2011View details ↗
Phase 2RecruitingNCT00501826 ↗

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

👨‍⚕️ Farhad Ravandi-Kashani, M.D. Anderson Cancer Center📍 1 site📅 Started Jul 2007View details ↗
← PreviousPage 7 of 7

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →